InventisBio Co., Limited (SHA:688382)
11.71
-0.68 (-5.49%)
At close: Nov 17, 2026
InventisBio Market Cap
InventisBio has a market cap or net worth of 6.79 billion as of November 16, 2026. It is the 9,433rd most valuable company in the world and the 2,036th biggest in China. Its market cap has decreased by 58.09% in one year.
Market Cap
6.79B
Enterprise Value
5.57B
Revenue
71.06M
Global Rank
Country Rank
#2,036 China
PE Ratio
n/a
ChartMarket Cap Chart
Since July 25, 2022, InventisBio's market cap has decreased from 8.79B to 6.79B, a decrease of -22.80%. That is a compound annual growth rate of -5.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 6.79B | -56.92% |
| Dec 31, 2025 | 15.75B | 105.38% |
| Dec 31, 2024 | 7.67B | -11.89% |
| Dec 29, 2023 | 8.71B | 14.01% |
| Dec 30, 2022 | 7.64B | -13.15% |
| Jul 25, 2022 | 8.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novoprotein Scientific | 7.94B |
| Vcanbio Cell & Gene Engineering Corp., | 7.39B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 7.18B |
| Jiangxi Fushine Pharmaceutical | 7.11B |
| Daan Gene | 7.10B |
| Novogene | 7.03B |
| BeBetter Med | 6.97B |
| Chengdu Easton Biopharmaceuticals | 6.95B |